尿激酶疏通深静脉导管血凝性堵管循证护理效果观察

doi:10.3760/cma.j.issn.1007-1245.2022.09.030

国际医药卫生导报 ›› 2022, Vol. 28 ›› Issue (9): 1309-1312.DOI: 10.3760/cma.j.issn.1007-1245.2022.09.030

尿激酶疏通深静脉导管血凝性堵管循证护理效果观察

岑瑞贤黄雪欢陈志宏许育花蔡玉清冯玉娣王彩珠陈惠红黄运红朱密仪刘燕仪钟结珍吴泉

广州市胸科医院内四科，广州　510095

收稿日期:2021-10-12 出版日期:2022-05-01 发布日期:2022-05-11
通讯作者: 黄雪欢，Email：hxh-361@163.com

Effect of evidence-based nursing of urokinase in dredging blood coagulation blockage of deep venous catheter

Cen Ruixian, Huang Xuehuan, Chen Zhihong, Xu Yuhua, Cai Yuqing, Feng Yudi, Wang Caizhu, Chen Huihong, Huang Yunhong, Zhu Miyi, Liu Yanyi, Zhong Jiezhen, Wu Quan

Fourth Department of Internal Medicine, Guangzhou Chest Hospital, Guangzhou 510095, China

Received:2021-10-12 Online:2022-05-01 Published:2022-05-11
Contact: Huang Xuehuan, Email: hxh-361@163.com

摘要/Abstract

摘要： 目的　观察在尿激酶疏导深静脉导管血凝性堵管中实施循证护理的方法及效果。方法　选取2019年1月至2021年5月间在广州市胸科医院接受各种深静脉导管治疗患者720例为研究对象，其中62例为外周静脉穿刺中心静脉置管（PICC）和中心静脉导管（CVC）血凝性堵管，男37例，女25例，年龄22～73（41.53±4.10）岁。根据研究方案，其中31例采用三通开关负压技术通管，31例采用2 ml注射器负压技术通管，均采取尿激酶疏通方案并实施循证护理干预，所有数据采用XLS统计并采用SPSS 18.0软件总结分析62例患者的导管再通率及凝血功能及血小板变化情况。结果　经实施循证护理干预，三通开关负压疏通法复通率达到83.87%（26/31），2 ml注射器负压疏通法复通率达到100.00%（31/31），两种疏通方法比较，差异有统计学意义（χ²=33.055，P<0.05）。凝血功能指标中D2聚体指标正常者9例，偏高者53例；纤维蛋白原指标正常者12例，偏高者50例；血小板检测结果显示正常者50例，偏高者9例，偏低者3例。未对临床治疗产生影响，未对导管功能造成影响，未造成导管损伤。结论　经长期临床实践研究证实，实施循证护理可显著提升PICC、CVC等深静脉导管的再通率，保障临床治疗顺利实施，具有较高的临床推广应用价值。

关键词: 深静脉导管, 血凝性堵管, 尿激酶, 循证护理

Abstract: Objective　To observe the methods and effect of evidence-based nursing in urokinase to relieve hemagglutinative occlusion of deep venous catheter. Methods　A total of 720 patients who received various deep venous catheter treatments in Guangzhou Chest Hospital between January 2019 and May 2021 were selected as the research objects. Among them, 62 patients had peripherally inserted central catheterization (PICC) and central vein catheter (CVC) hemagglutinative occlusions, including 37 males and 25 females, and they were 22-73 (41.53±4.10) years old; according to the research plan, 31 cases used three-way switch negative pressure technology to open the tubes, and 31 cases used 2 ml syringe negative pressure technology to open the tubes; urokinase was used to dredge the catheters and evidence-based nursing intervention was implemented in both groups. All the data were calculated using XLS, and SPSS 18.0 software was used to summarize and analyze the catheter recanalization rate, coagulation function, and platelet changes of the 62 patients. Results　After the implementation of evidence-based nursing intervention, the recanalization rate of the three-way switch negative pressure dredging method reached 83.87% (26/31), and the recanalization rate of the negative pressure dredging method of 2 ml syringe reached 100.00% (31/31), with a statistical difference (χ²=33.055, P<0.05). Among the coagulation function indicators, the D2 aggregate was normal in 9 cases and high in 53 cases; the fibrinogen was normal in 12 cases and high in 50 cases; the platelet test was normal in 50 cases, high in 9 cases, and low in 3 cases. It did not affect the clinical treatment and catheter function, and did not cause catheter damage. Conclusion　Long-term clinical practice studies have confirmed that the implementation of evidence-based nursing can significantly increase the recanalization rate of PICC, CVC, and other deep venous catheters and ensure the smooth implementation of clinical treatments, so it is worth being clinically generalized.

Key words: Deep venous catheter, Hemagglutinative occlusion, Urokinase, Evidence-based nursing

岑瑞贤, 黄雪欢, 陈志宏, 许育花, 蔡玉清, 冯玉娣, 王彩珠, 陈惠红, 黄运红, 朱密仪, 刘燕仪, 钟结珍, 吴泉. 尿激酶疏通深静脉导管血凝性堵管循证护理效果观察[J]. 国际医药卫生导报, 2022, 28(9): 1309-1312.

Cen Ruixian, Huang Xuehuan, Chen Zhihong, Xu Yuhua, Cai Yuqing, Feng Yudi, Wang Caizhu, Chen Huihong, Huang Yunhong, Zhu Miyi, Liu Yanyi, Zhong Jiezhen, Wu Quan. Effect of evidence-based nursing of urokinase in dredging blood coagulation blockage of deep venous catheter[J]. International Medicine and Health Guidance News, 2022, 28(9): 1309-1312.

参考文献

[1] 浦亚楼,孟爱凤,刘春丽,等.PICC血凝性堵管风险预警评估及相关预防措施的研究进展[J].护士进修杂志,2019,34(20):1857-1860.DOI:10.16821/j.cnki.hsjx.2019.20.007.

[2] 王娟,胡斌.早期尿激酶封管在血液透析患者长期深静脉留置导管中应用研究进展[J].现代医药卫生,2019,35(11):1674-1677.DOI:10.3969/j.issn.1009-5519.2019.11.024.

[3] 白艳红.PICC患者发生静脉血栓的危险因素和预防的研究进展[J].保健文汇,2019,(1):219.DOI:10.3969/j.issn.1671-5217.2019.01.217.

[4] 洪国标,宋利,全梓林,等.动静脉内瘘类型对尿激酶溶栓治疗效果的影响[J].国际医药卫生导报,2021,27(8):1115-1118.DOI:10.3760/cma.j.issn.1007-1245.2021. 08.002.

[5] 翟慧鹏.尿激酶在PICC导管堵塞后溶栓治疗的应用[J/CD].世界最新医学信息文摘(连续型电子期刊),2019,19(48):148,150.DOI:10.19613/j.cnki.1671-3141.2019.48.097.

[6] 林华,连家红,吴怡苗,等.循证护理在血液透析长期留置中心静脉导管患者中的应用效果[J].护理实践与研究,2019,16(10):38-40.DOI:10.3969/j.issn.1672-9676.2019. 10.015.

[7] 袁建涛,赵丹,卢亚改.肿瘤患者实施循证护理对深静脉长期留置导管感染的预防效果[J].中外医学研究,2020,18(17):83-85.DOI:10.14033/j.cnki.cfmr.2020.17.034.

[8] 黄冬琴,吴蔓.不同剂量尿激酶经导管溶栓治疗下肢深静脉血栓形成的疗效[J].医学信息,2020,33(10):122-123.DOI:10.3969/j.issn.1006-1959.2020.10.034.

[9] 阮孟英,金名巩,方文卿,等.两种尿激酶给药方案治疗尿毒症血液透析患者中心静脉导管功能不良临床疗效比较[J].微循环学杂志,2019,29(1):94-95.DOI:10.3969/j.issn. 1005-1740.2019.01.021.

尿激酶疏通深静脉导管血凝性堵管循证护理效果观察

Effect of evidence-based nursing of urokinase in dredging blood coagulation blockage of deep venous catheter

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 1

编辑推荐

Metrics